Fundraising Fox

Alcon

NYSE: ALC

Fort Worth, US · Incorporated in Switzerland · 1 known investors

Find your way into Alcon

70 people in our graph share verified history with the Alcon team — schools, employers, funds. One of them is your warm intro.

Jim Caggianounlockedknows David Endicott · together at Allergan (overlapped)
×7knows the team · via Allergan
×2knows the team · via Alcon
×2knows the team · via Whitman College

Alcon is a global eye care company that develops and manufactures ophthalmologic products and surgical systems to improve vision. The company serves patients, surgeons, and underserved communities worldwide through product innovation, surgeon training programs, and vision screening initiatives.

Founders & leadership

DEDavid Endicott
David EndicottinCEOHe became CEO in 2018 when Alcon was part of Novartis and led the company through its separation and public listing in 2019.

Investors · 1

Competitors · 4

by search overlap

Companies competing with Alcon for the same Google search keywords, organic and paid, via search-intersection analysis.

Acquisitions · 1

Early investors' stakes continue via these deals
Transcend

Developed a glaucoma treatment device reducing intra-ocular pressure; acquired by Alcon/Novartis for up to $740M.

In the news

Frequently asked questions

What does Alcon do?
Alcon is a global eye care company that develops and manufactures ophthalmologic products and surgical systems to improve vision. The company serves patients, surgeons, and underserved communities worldwide through product innovation, surgeon training programs, and vision screening initiatives.
Who are Alcon's investors?
Alcon's investors include Windham Capital Partners.
Where is Alcon headquartered?
Alcon is headquartered in Fort Worth, US.